treatment pulmonary infection patient cystic fibrosis comparative study ticarcillin gentamicin effectiveness ticarcillin pseudomonas aeruginosa acute exacerbation pulmonary infection patient cystic fibrosis evaluated seventyone percent patient treated ticarcillin alone responded favorably response rate similar patient treated combination ticarcillin plus gentamicin gentamicin alone severity underlying disease important determinant response treatment ticarcillin resistant organism recovered treatment 50 patient received drug recovery prevented inclusion gentamicin therapeutic regimen interfere clinical improvement ticarcillinresistant strain persisted followup two six month completion therapy one ten patient serious toxicity ticarcillin noted study period